04 July 2011

Indian IPOs and NCDs (bonds)- Listing premium expectation (grey market)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� �


Company Name
Offer Price (Rs)
Expected Listing Price Premium
Shriram Transport Finance  Bond
1000
3% - 4%
IFCI Bonds
10,000
2% - 3%
Birla Pacific Medspa
10
1
Rushil Decor
72
Discount
Readymade Steel
90 to 108
1
Bharatiya Global Infomedia
75 to 82
1- 1.50


India Telecom - Store visit indicates not only are tariffs rising, retailer commissions are going down too : Credit Suisse

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


● Our recent meetings with telcos showed managements’ intention
to raise tariffs in the sector, which hinted at abating competition.
● Mumbai is probably the most competitive telecom market across
22 circles in India, with 12 operators offering services here. So any
tariff changes here would be reflective of the competitive
pressures in the sector as a whole.
● In this context, we surveyed a few mobile retailers in central
Mumbai this week. Our discussions indicated that operators have
started making minor changes (increases) to tariff plans over the
last few weeks.
● The changes are centred on special tariff vouchers, which are
promotional in nature and not regulated.
● In addition, dealer commissions have come down across
operators over the last few weeks—this would not affect RPMs but
have a direct impact on margins.
● We believe rising tariffs and falling sub-acquisition costs should
lead to margin improvement for telcos. We retain our positive
outlook on Bharti and Idea.

FII & DII trading activity on NSE and BSE as on 04-Jul-2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII trading activity on NSE and BSE on Capital Market Segment
The following is combined FII trading data across NSE and BSE collated on the basis of trades executed by FIIs on 04-Jul-2011.
FII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores)
CategoryDateBuy ValueSell ValueNet Value
FII04-Jul-20112820.061688.341131.72

 
 
Domestic Institutional Investors trading activity on NSE and BSE on Capital Market Segment
The following is combined Domestic Institutional Investors trading data across NSE and BSE collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System on 04-Jul-2011.
DII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores)
CategoryDateBuy ValueSell ValueNet Value
DII04-Jul-2011982.131351.45-369.32
 
 


-- 

FII DERIVATIVES STATISTICS FOR 04-Jul-2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII DERIVATIVES STATISTICS FOR 04-Jul-2011 
 BUYSELLOPEN INTEREST AT THE END OF THE DAY 
 No. of contractsAmt in CroresNo. of contractsAmt in CroresNo. of contractsAmt in Crores 
INDEX FUTURES535851515.4429012784.3044342312504.01731.15
INDEX OPTIONS1622474508.031262733485.15106011429951.911022.88
STOCK FUTURES32458879.08370481039.47104310329743.68-160.39
STOCK OPTIONS6431164.837423193.2115574414.66-28.37
      Total1565.26

 
 

-- 

BSE, Bulk deals, 04/7/2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Deal DateScrip CodeCompanyClient NameDeal Type *QuantityPrice **
4/7/2011524412Aarey DrugsSHAISHIL TUSHARKUMAR JHAVERIB5470024.39
4/7/2011524412Aarey DrugsVIPUL PANNALAL SHAHB2586723.55
4/7/2011524412Aarey DrugsVIPUL VIRENDRAKUMAR PATELB5000023.45
4/7/2011524412Aarey DrugsBHAVNABEN VIRENDRAKUMAR PATELB5000023.90
4/7/2011524412Aarey DrugsRAGINI RUPEN SHAHB5000023.95
4/7/2011524412Aarey DrugsHARSHA J RADADIYAB5000023.40
4/7/2011524412Aarey DrugsRAGINI RUPEN SHAHS5000023.45
4/7/2011524412Aarey DrugsVIPUL VIRENDRAKUMAR PATELS5000023.95
4/7/2011524412Aarey DrugsBHAVNABEN VIRENDRAKUMAR PATELS5000024.40
4/7/2011524412Aarey DrugsVIPUL PANNALAL SHAHS2576723.60
4/7/2011524412Aarey DrugsARVINDBHAI KHODABHAI PATELS2535523.40
4/7/2011524412Aarey DrugsSHAISHIL TUSHARKUMAR JHAVERIS5470023.81
4/7/2011533321Bil Energy SysPRATEEK VINOD KUMAR JATIAB12031325.20
4/7/2011533321Bil Energy SysVEEDHATA TOWERS PRIVATE LIMITEDS11500025.19
4/7/2011511196Can Fin HomesRAJEN CHANDRAKANT SHETHB286452117.23

NSE, Bulk deals, 04-Jul-2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


DateSymbolSecurity NameClient NameBuy / SellQuantity TradedTrade Price /
Wght. Avg.
Price
Remarks
04-Jul-2011ACROPETALAcropetal Tech LtdINDRAVARUN TRADE IMPEX PVT LTDBUY1,91,60017.26-
04-Jul-2011ACROPETALAcropetal Tech LtdINDRAVARUN TRADE IMPEX PVT LTDSELL1,99,06917.09-
04-Jul-2011AGREAgre Developers LtdPILOT CONSULTANTS PRIVATE LIMITEDBUY80,00051.63-
04-Jul-2011BEDMUTHABedmutha Indust LtdJAYNEEL SECURITIES PRIVATE LIMITEDBUY1,49,941132.08-
04-Jul-2011BEDMUTHABedmutha Indust LtdJAYNEEL SECURITIES PRIVATE LIMITEDSELL1,37,809132.30-
04-Jul-2011BEDMUTHABedmutha Indust LtdSAAKSHI SHARES PVT.LTD.BUY1,30,744133.44-
04-Jul-2011BEDMUTHABedmutha Indust LtdSAAKSHI SHARES PVT.LTD.SELL80,744131.53-
04-Jul-2011BILENERGYBil Energy Systems LtdOMPRAKASH ENGINEERING PRIVATE LIMITEDSELL60,00025.

4/7/11; Categories Turnover (Rs. crore) Clients NRI Proprietary

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



 Categories Turnover
(Rs. crore)
ClientsNRIProprietary
Trade DateBuySalesNetBuySalesNetBuySalesNet
4/7/111,682.762,108.30-425.540.661.10-0.44548.02538.399.63
1/7/111,825.281,820.095.191.1114.75-13.65634.22627.087.14
30/6/111,832.101,893.35-61.251.170.690.48602.05570.3931.66
Jul , 113,508.043,928.40-420.361.7615.85-14.091,182.241,165.4716.77
Since 1/1/11274,060.91279,206.15-5,145.24150.69142.618.0878,616.1978,077.56538.63

4/7/11; FII & DII Turnover (BSE + NSE) (Rs. crore)

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII & DII Turnover (BSE + NSE)
(Rs. crore)
FIIDII
Trade DateBuySalesNetBuySalesNet
4/7/112,820.061,688.341,131.72982.131,351.45-369.32
1/7/112,603.522,003.86599.661,044.681,499.99-455.31
30/6/115,361.853,770.511,591.341,180.971,954.35-773.38
Jul , 115,423.583,692.201,731.382,026.802,851.45-824.65
Since 1/1/11   *331,654.81338,892.77-7,237.96149,719.65136,033.0713,686.58

BUY BPCL — Raise PO by 14% but prefer HPCL ::BofA Merrill Lynch,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


BPCL — Raise PO by 14% but prefer HPCL
Country Overview
Raise PO by 14% to Rs739 to reflect likely re-rating; Neutral
The government on June 24 hiked fuel prices and cut taxes to cut subsidy by over
US$10bn. However, there is no clarity on subsidy sharing. It is therefore difficult
to estimate the gains from subsidy cut especially to R&M companies. Therefore
changes in BPCL’s FY12-FY13 EPS are modest. However, investors are likely to
be enthused by the fact that diesel would be deregulated if oil price declines by
11%. To reflect the likely re-rating we have raised PE multiple used to value
BPCL to 9.5x from 8x earlier. This has meant 14% upgrade in its PO to Rs739.
BPCL has the best leverage to reforms among R&M but we prefer HPCL, which
is cheaper and we think also has good leverage to reforms. We retain our
Neutral..
R&M companies high risk-high return play on reforms
R&M companies’ stock price always reacts more positively to reforms than
upstream. R&M company stocks were up far more than upstream peers after the
fuel price hikes in June 2010. HPCL was the best performer followed by BPCL.
Risks to R&M: high share in subsidy & large inventory loss
The main driver of R&M earnings is compensation of subsidy from government
and upstream. High share in subsidy is thus one of the risks. The other risk is
large inventory loss due to steep decline in oil price. In FY09 R&M companies
had their lowest earnings due to inventory loss despite not having to bear any
subsidy.
Expect investors to look at the glass as half full
R&M earnings are difficult to predict but this may also mean positive surprise like
in FY10-FY11. There was unexpectedly higher compensation from upstream in
FY11 and from government in FY10. This should make investors optimistic. Even
in case of large inventory loss due to oil price collapse investors may focus on the
better outlook for FY13 rather than the poor outlook in FY12.